Rj. Cohen et al., IMMUNOHISTOCHEMICAL DETECTION OF ONCOGENE PROTEINS AND NEUROENDOCRINEDIFFERENTIATION IN DIFFERENT STAGES OF PROSTATE-CANCER, Pathology, 27(3), 1995, pp. 229-232
The progression of prostatic adenocarcinoma from localized disease to
metastatic carcinoma appears to be a multi-step sequence. The expressi
on of common oncogenes/oncosuppressor genes and the mediating effect o
f neuroendocrine tumor cells may play a role in this progression. The
expression of the more frequently investigated oncogenes/oncosuppresso
r genes (p53, c-myc, c-erbB-2, bcl-2) and the presence of neuroendocri
ne cells were assessed in prostatic cancer tissue from patients with l
ocalized and metastatic cancer. These oncogenes/oncosuppressor genes w
ere evaluated according to tumor stage and grade and their relationshi
p to one another. Grade was not related to any of the oncogene markers
or to the presence of neuroendocrine cells. Advancing stage was assoc
iated with a significant increase in p53 expression, while other marke
rs remained constant in all stages. Neuroendocrine cells, p53, c-myc,
c-erbB-2 and bcl-2 were rarely co-expressed at any stage of prostate c
ancer.